Back

Cost-effectiveness analysis of implementing the Nagasaki Acute Myocardial Infarction (AMI) secondary prevention clinical pathway

31 August 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular health: from treatment strategies to lifestyle adherence Health Economics ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masaya Kurobe

Nagasaki University Hospital, Nagasaki (Japan)

7 More presentations in this session

Presentation thumbnail
Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine according to time of day of vaccination: a post-hoc analysis of the DANFLU-1 randomised clinical trial
Mr J. Christensen (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Real world economic evaluation of CT-FFR in patients with suspected coronary artery disease
Doctor J. Peper (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Type 2 diabetes rather than the presence of significant coronary stenoses is associated with quality of life in angiographied coronary patients
Associate Professor H. Drexel (Feldkirch, AT) Doctor B. Larcher (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?
Doctor C. Camm (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Free fatty acids and mortality among adults in the United States: a report from US National Health and Nutrition Examination Survey (NHANES)
Doctor M. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular health: from treatment strategies to lifestyle adherence

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Cost-effectiveness of statin therapy for primary prevention of cardiovascular disease based on different LDL-C targets: a modelling study
thumbnail
Congress Presentation
NET-COST-HFrEF: A NETwork meta-analysis with COST-effectiveness evaluation in HFrEF
thumbnail
Congress Presentation
Quality of care and cost-effectiveness: towards a more affordable healthcare system

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources